HomeInsightsStock Comparison

Emcure Pharmaceuticals Ltd vs Natural Capsules Ltd Stock Comparison

Emcure Pharmaceuticals Ltd vs Natural Capsules Ltd Stock Comparison

Last Updated on: Jul 07, 2025

Key Highlights

  • The Latest Trading Price of Emcure Pharmaceuticals Ltd is ₹ 1246 as of 07 Jul 10:30.
  • The P/E Ratio of Emcure Pharmaceuticals Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Natural Capsules Ltd changed from 23.8 on March 2020 to 51.3 on March 2024 . This represents a CAGR of 16.60% over 5 years.
  • The Market Cap of Emcure Pharmaceuticals Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Natural Capsules Ltd changed from ₹ 20.47 crore on March 2020 to ₹ 284.77 crore on March 2024 . This represents a CAGR of 69.31% over 5 years.
  • The revenue of Emcure Pharmaceuticals Ltd for the Mar '25 is ₹ 2120 crore as compare to the Dec '24 revenue of ₹ 1959 crore. This represent the growth of 8.23% The revenue of Natural Capsules Ltd for the Mar '25 is ₹ 45.27 crore as compare to the Dec '24 revenue of ₹ 43.94 crore. This represent the growth of 3.03%.
  • The ebitda of Emcure Pharmaceuticals Ltd for the Mar '25 is ₹ 396.48 crore as compare to the Dec '24 ebitda of ₹ 358.5 crore. This represent the growth of 10.59% The ebitda of Natural Capsules Ltd for the Mar '25 is ₹ 4.69 crore as compare to the Dec '24 ebitda of ₹ 4.38 crore. This represent the growth of 7.08%.
  • The net profit of Emcure Pharmaceuticals Ltd changed from ₹ 140.97 crore to ₹ 197.24 crore over 8 quarters. This represents a CAGR of 18.29% The net profit of Natural Capsules Ltd changed from ₹ 1.82 crore to ₹ 0.52 crore over 8 quarters. This represents a CAGR of -46.55% .
  • The Dividend Payout of Emcure Pharmaceuticals Ltd changed from 25.8 % on March 2020 to 22.53 % on March 2024 . This represents a CAGR of -2.67% over 5 yearsThe Dividend Payout of Natural Capsules Ltd changed from 43.47 % on March 2020 to 0 % on March 2024 . This represents a CAGR of -100.00% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Emcure Pharmaceuticals Ltd

  • Emcure Pharmaceuticals Limited was originally incorporated as Emcure Pharmaceuticals Private Limited', as a Private Company, pursuant to a Certificate of Incorporation dated April 16, 1981 issued by Registrar of Companies, Maharashtra at Bombay.
  • Subsequently, Company was converted into a Public Company and the name of Company was changed to Emcure Pharmaceuticals Limited', through a fresh Certificate of Incorporation issued by the RoC, Maharashtra in Pune on September 18, 2001. Emcure Pharmaceuticals an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
  • They are a research and development driven company with a differentiated product portfolio that includes orals, injectables and biotherapeutics, which has enabled to reach target markets across over 70 countries, with a strong presence in India, Europe and Canada.

About Natural Capsules Ltd

  • Natural Capsules Limited was incorporated as Public Limited Company established in 1993 at Bangalore.
  • The Company is one of the leading manufacturers of hard capsule shells in India.
  • The Company introduced vegetarian capsules to Indian market and is the second-largest manufacturer of gelatin capsules in the country. NCL expanded its operations to Puducherry in 2003, further solidifying its position as a trusted brand in the industry.
  • By venturing into API manufacturing under its subsidiary, Natural Biogenex Private Limited, Company presently operates two distinct business verticals-Capsules and APIs.
  • The company is a well-equipped modern manufacturing plant to manufacture Hard Gelatin Capsule shells, Hard Cellulose Capsule shells and Pharmaceutical Dosage Forms in Capsule Dosage Form. The Company meets the statutory requirements as laid down by the authorities in respect to cGMP and cGLP practices.

Emcure Pharmaceuticals Ltd News Hub

News

Board of Emcure Pharmaceuticals recommends final dividend

Emcure Pharmaceuticals announced that the Board of Directors of the Company at its meeting...

Read more

22 May 2025 18:02

News

Emcure Pharmaceuticals to announce Quarterly Result

Emcure Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 22 ...

Read more

14 May 2025 15:15

News

Emcure Pharma's pune facility receives VAI status from USFDA

The company received the Establishment Inspection Report (EIR) from the USFDA following an...

Read more

21 Apr 2025 11:09

News

Emcure subsidiary Tillomed Laboratories to acquire UK based Manx Healthcare and its subsidiaries

Tillomed Laboratories, a subsidiary of Emcure Pharmaceuticals, has entered into an Asset P...

Read more

04 Apr 2025 12:28

News

Emcure Pharma's European arm acquires Manx Healthcare for '19.7 million

The APA has also been inked with the subsidiaries of Manx, viz. Manx Pharma and Manx Gener...

Read more

04 Apr 2025 14:05

News

Emcutix Biopharmaceuticals inks in-licensing agreement with WiQo

Emcutix Biopharmaceuticals, a wholly owned subsidiary of Emcure Pharmaceuticals, announced...

Read more

02 Apr 2025 10:35

Natural Capsules Ltd News Hub

News

Natural Capsules declare Quarterly Result

Natural Capsules will hold a meeting of the Board of Directors of the Company on 29 May 20...

Read more

23 May 2025 20:27

News

Natural Capsules schedules board meeting

Natural Capsules will hold a meeting of the Board of Directors of the Company on 12 Februa...

Read more

06 Feb 2025 13:40

News

Natural Capsules to table results

Natural Capsules will hold a meeting of the Board of Directors of the Company on 12 Novemb...

Read more

05 Nov 2024 13:47

News

Natural Capsules to hold board meeting

Natural Capsules will hold a meeting of the Board of Directors of the Company on 5 Septemb...

Read more

03 Sep 2024 11:09

News

Natural Capsules to table results

Natural Capsules will hold a meeting of the Board of Directors of the Company on 13 August...

Read more

07 Aug 2024 13:56

News

Natural Capsules schedules EGM

Natural Capsules announced that an Extra Ordinary General Meeting (EGM) of the Company wil...

Read more

29 Jul 2024 13:39

SWOT Analysis Of Natural Capsules Ltd

Strength

2

S

Weakness

3

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Emcure Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Natural Capsules Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Emcure Pharmaceuticals Ltd and Natural Capsules Ltd

Which company has a larger market capitalization, Emcure Pharmaceuticals Ltd or Natural Capsules Ltd?

Market cap of Emcure Pharmaceuticals Ltd is 23,759 Cr while Market cap of Natural Capsules Ltd is 225 Cr

What are the key factors driving the stock performance of Emcure Pharmaceuticals Ltd and Natural Capsules Ltd?

The stock performance of Emcure Pharmaceuticals Ltd and Natural Capsules Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Emcure Pharmaceuticals Ltd and Natural Capsules Ltd?

As of July 7, 2025, the Emcure Pharmaceuticals Ltd stock price is INR ₹1253.75. On the other hand, Natural Capsules Ltd stock price is INR ₹218.4.

How do dividend payouts of Emcure Pharmaceuticals Ltd and Natural Capsules Ltd compare?

To compare the dividend payouts of Emcure Pharmaceuticals Ltd and Natural Capsules Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions